ZNG Medical
ZNG Medical
The global insulin syringes and pen injectors market is witnessing an unprecedented surge, driven by the increasing prevalence of diabetes mellitus worldwide. According to recent health statistics, over 537 million adults are currently living with diabetes, a number projected to rise significantly by 2045. This demographic shift has transformed Insulin Syringes and Pen Injectors from simple medical consumables into high-tech precision instruments essential for daily survival and quality of life.
In the industrial sphere, the transition from traditional syringes to Insulin Pen Injectors represents a move toward patient-centric care. Hospitals, clinics, and home-care providers are increasingly seeking products that offer minimal pain, maximum dose accuracy, and portable convenience. This demand is met by top-tier China factories that leverage advanced automation and medical-grade materials to supply the world's pharmacy chains and medical distributors.
Founded in 1996, Zhejiang ZNG Medical has established itself as a cornerstone of the medical device industry in China. With over two decades of experience, we specialize in the R&D and production of high-end injection products. Our commitment to excellence is backed by ISO 9001 quality systems and CE product certifications, ensuring that every needle and pen injector we produce meets international safety benchmarks.
Our production capabilities extend far beyond standard insulin syringes. We are a comprehensive hub for medical needles:
The industry is moving toward "Smart Injection" ecosystems. As a leading manufacturer, we are tracking several key trends that define the next decade of procurement:
Minimizing patient trauma through 32G and 33G ultra-thin needles, requiring sophisticated metallurgical processes that ZNG has mastered.
Transitioning from single-use plastics to durable, medical-grade metal reusable pens that reduce environmental impact.
Global brands now require bespoke branding, unique color coding for different insulin types, and localized dosage scales (IU/mg).
For global procurement officers, the focus has shifted from mere "cost per unit" to "total value of partnership," which includes regulatory compliance, lead-time reliability, and the ability to scale production for government tenders.
Our factory utilizes state-of-the-art cleanrooms and automated assembly lines to ensure sterile, high-precision output.
Producing Cannula
Injection Molding
Precision Assembling
Sterilized by EO
In the competitive world of medical supply, choosing a China Insulin Syringe Factory offers distinct advantages that combine economic efficiency with high-tier technology.
We provide full documentation (CE, ISO) necessary for local market entry in Europe, Southeast Asia, and the Americas.
Our facility can handle massive volume orders without compromising the micrometer-level precision required for insulin dosage.
From different color casings to customized peptide delivery pens, we turn your product designs into clinical realities.
Whether it is for a pharmacy chain in Brazil or a hospital group in Germany, our Insulin Pen Injectors are designed to bridge the gap between clinical requirements and patient comfort. We understand localized application scenarios—from home-use auto-injectors to single-dose prefilled pens used in busy healthcare settings.
